Reparagen^® Pro

What is the Next Generation in Joint Health that addresses not only the symptoms but the causes? Reparagen^® Pro

Reparagen Pro represents a revolutionary new approach to joint health. It’s the first supplement to work at a genetic level to target the three main areas of joint function: a healthy inflammatory response^2,4, the body’s normal breakdown of cartilage¹¹ and its ability to rebuild and replace it^7,8. It combines three different ingredients – Vincaria^®, RNI 249^® and Progrado^® - and two separate clinical trials^3,9 to address these three main areas of joint health and maintenance.

Only $34.95 ($1.17/day)

A New Approach to Joint Health

Reparagen Pro consists of three patented, all natural extracts: Vincaria^®, RNI 249^® and Progrado^®. Each regulates different forms of gene expression specific to joint health. Vincaria has been shown to affect NFkB, the main “on-off switch” for a healthy inflammatory response; RNI 249 causes human cells to produce IGF-1, the master regulator for rebuilding cartilage; and, Progrado has been shown to attenuate the activity of MMPs, the molecular “scissors” that are responsible for the body’s normal breakdown of cartilage.

• 9 out of ten participants in a clinical trial taking a single 100mg dose of Vincaria a day experienced significant improvement in joint health. Reparagen Pro contains three times this effective dose³
• 93% of participants in a clinical trial taking the Vincaria-RNI 249 combination (aka Reparagen) had considerable increases in both mobility and flexibility⁹
• In a study with Case Western Reserve University, Progrado stopped the breakdown of cartilage cells¹¹

Clinically validated, Reparagen Pro combines the best of nature with the power of science to promote and maximize proper and healthy joint function.

1 USPTO #6,797,286
2 Aliment Pharmacol Ther 1998; 12: 1279±1289.
3 Inflammation Res, 2001, 50:442–448
4 Free Rad Bio Medicine, 2000, 29(1):71–78
5 N Eng J Med, 2006, 354:795-808
6 2007 Gallup Study of Joint Health and Glucosamine
7 Inflammation Research 54: Supplement 2, pp 115, 2005
8 BMC Complementary and Alternative Medicine 2006, 6:13
9 BMC Complementary and Alternative Medicine 2007, 7:34
10 US NIH Grant No 1R43AG024733-01
11 Journal of Translational Medicine 2008, 6:3